Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite

Hematocrit-lowering Effect Following Inactivation of Renin-Angiotensin System with Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-02 ,pp. : 483-486

Bentham Science Publishers

Access to resources Recommend Favorite

Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors: A Systematic Review and Meta-Analysis

By Caldeira Daniel   David Cláudio   Sampaio Cristina  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 263-277

Adis International

Access to resources Recommend Favorite

Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 501-507

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in Experimental Myocarditis

By  

Current Pharmaceutical Design, Vol. 9, Iss. 9, 2003-04 ,pp. : 723-735

Bentham Science Publishers

Access to resources Recommend Favorite